Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2NET 1

Conditions

Neuroendocrine Tumors 50Pancreatic Neoplasms 6Gastrointestinal Neoplasms 6Stomach Neoplasms 5Carcinoma, Hepatocellular 5Colorectal Neoplasms 4Rectal Neuroendocrine Tumor 3Prostatic Neoplasms 3Neoplasm Metastasis 3Liver Neoplasms 3Esophageal Neoplasms 3Cholangiocarcinoma 3Thyroid Neoplasms 2Rectal Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Gastro-enteropancreatic neuroendocrine tumor 2Colonic Neoplasms 2Carcinoma, Neuroendocrine 2Carcinoma 2Carcinoid Tumor 2Biliary Tract Neoplasms 2Appendiceal Neoplasms 2Anus Neoplasms 2Visceral Pain 1Serotonin Syndrome 1Recurrence 1Rectal Neuroendocrine Tumors 1Pheochromocytoma 1Patients With Gastroenteropancreatic Neuroendocrine Tumors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Serotonin Syndrome × NET × Clear all
NCT04073017 2021-05-21

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
11 enrolled
EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡